4DMedical
Perth, Australia· Est.
Contrast‑free quantitative lung imaging platform for respiratory diagnostics.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Contrast‑free quantitative lung imaging platform for respiratory diagnostics.
RespiratoryPulmonary
Technology Platform
Proprietary X‑ray Velocimetry (XV) and CT‑VQ (ventilation/perfusion) imaging that quantifies regional lung ventilation and perfusion from standard X‑ray or CT scans without contrast.
Opportunities
Rapid expansion into US and EU markets post‑regulatory clearance, and with AI analytics, and leveraging growing demand for quantitative, non‑invasive respiratory diagnostics.
Risk Factors
Adoption hinges on reimbursement acceptance, clinician workflow integration, and competition from established imaging OEMs offering functional imaging solutions.
Competitive Landscape
Competes with major imaging vendors (Siemens, Philips, GE) and emerging AI‑driven lung analytics firms; differentiation lies in contrast‑free, regional ventilation/perfusion quantification and low‑dose imaging.